News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Conference News ISC 2020 Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era Todd Neale February 29, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News Meta-analysis Questions PCI vs CABG in Women With Multivessel Disease Shelley Wood February 27, 2020
News Daily News Acute MI Symptom Clustering Differs in Men and Women: VIRGO Michael O'Riordan February 21, 2020
News Daily News PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching Shelley Wood February 19, 2020
News Daily News Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises Shelley Wood February 14, 2020
News Daily News FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns Shelley Wood February 14, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News Trials of New Cancer Drugs Failing to Address Potential CV Risks Todd Neale February 10, 2020
News Daily News Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis Caitlin E. Cox February 07, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Conference News ISET 2020 PERT Data Emerge, Though the Exact Strategy Isn’t a Done Deal Caitlin E. Cox January 30, 2020
News Daily News Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol Yael L. Maxwell January 28, 2020
News Daily News Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA Michael O'Riordan January 21, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events Shelley Wood January 20, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020